SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 189 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31 | -96.8% | 51,794 | -93.0% | 0.00% | -100.0% |
| Q2 2023 | $964 | +13.1% | 741,806 | +53.2% | 0.01% | -10.0% |
| Q1 2023 | $852 | -99.8% | 484,151 | +302.4% | 0.01% | +100.0% |
| Q2 2022 | $498,000 | -12.8% | 120,316 | +57.8% | 0.01% | +66.7% |
| Q4 2021 | $571,000 | +65.5% | 76,247 | +98.6% | 0.00% | +50.0% |
| Q3 2021 | $345,000 | -65.6% | 38,393 | -54.2% | 0.00% | -77.8% |
| Q2 2021 | $1,002,000 | +237.4% | 83,755 | +339.5% | 0.01% | +50.0% |
| Q4 2020 | $297,000 | +206.2% | 19,058 | +84.5% | 0.01% | +100.0% |
| Q3 2020 | $97,000 | -47.3% | 10,329 | -49.2% | 0.00% | -66.7% |
| Q3 2019 | $184,000 | +46.0% | 20,351 | +78.5% | 0.01% | -84.7% |
| Q2 2015 | $126,000 | – | 11,400 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |